Kevin Strang

Stock Analyst at Goldman Sachs

(0.66)
# 4,186
Out of 4,988 analysts
6
Total ratings
n/a
Success rate
-16.5%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Kevin Strang

Praxis Precision Medicines
Aug 21, 2026
Rated: Buy
Price Target: $470$575
Current: $298.95
Upside: +92.34%
Stoke Therapeutics
Aug 3, 2026
Reiterated: Buy
Price Target: $44
Current: $28.43
Upside: +54.77%